Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03831932
Title Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center Birmingham Alabama 35233 United States Details
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146 United States Details
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442 United States Details
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 United States Details
UM Sylvester Comprehensive Cancer Center at Plantation Plantation Florida 33324 United States Details
University of Kentucky/Markey Cancer Center Lexington Kentucky 40536 United States Details
Case Western Reserve University Cleveland Ohio 44106 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) Pittsburgh Pennsylvania 15232 United States Details
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 United States Details
University of Virginia Cancer Center Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field